0P3C Stock Overview
Karolinska Development AB (publ) is a venture capital firm specializing in investments in growth capital, seed stage, and early stage companies.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 2/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
Karolinska Development AB (publ) Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | kr1.54 |
52 Week High | kr1.82 |
52 Week Low | kr1.46 |
Beta | 0.38 |
1 Month Change | -0.56% |
3 Month Change | -8.85% |
1 Year Change | -7.56% |
3 Year Change | -0.91% |
5 Year Change | n/a |
Change since IPO | -93.78% |
Recent News & Updates
Recent updates
Shareholder Returns
0P3C | GB Pharmaceuticals | GB Market | |
---|---|---|---|
7D | 0% | 1.8% | 2.0% |
1Y | -7.6% | 6.6% | 4.5% |
Return vs Industry: 0P3C underperformed the UK Pharmaceuticals industry which returned 6.6% over the past year.
Return vs Market: 0P3C underperformed the UK Market which returned 4.5% over the past year.
Price Volatility
0P3C volatility | |
---|---|
0P3C Average Weekly Movement | 4.0% |
Pharmaceuticals Industry Average Movement | 7.8% |
Market Average Movement | 4.8% |
10% most volatile stocks in GB Market | 11.4% |
10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: 0P3C has not had significant price volatility in the past 3 months.
Volatility Over Time: 0P3C's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2003 | 8 | Viktor Drvota | www.karolinskadevelopment.com |
Karolinska Development AB (publ) is a venture capital firm specializing in investments in growth capital, seed stage, and early stage companies. It seeks to invest in pharmaceutical research and development, medical research, healthcare technology, gene research and development, drug delivery technologies, biotechnology, and life science tools and service sectors. The firm seeks to invest in the Nordic region with a focus on Sweden, Iceland, Norway, Finland, and Denmark.
Karolinska Development AB (publ) Fundamentals Summary
0P3C fundamental statistics | |
---|---|
Market cap | kr420.40m |
Earnings (TTM) | kr33.61m |
Revenue (TTM) | kr1.94m |
12.5x
P/E Ratio217.0x
P/S RatioIs 0P3C overvalued?
See Fair Value and valuation analysisEarnings & Revenue
0P3C income statement (TTM) | |
---|---|
Revenue | kr1.94m |
Cost of Revenue | kr0 |
Gross Profit | kr1.94m |
Other Expenses | -kr31.67m |
Earnings | kr33.61m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 30, 2024
Earnings per share (EPS) | 0.12 |
Gross Margin | 100.00% |
Net Profit Margin | 1,734.95% |
Debt/Equity Ratio | 0% |
How did 0P3C perform over the long term?
See historical performance and comparison